X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (12) 12
hygiene (12) 12
medical or veterinary science (12) 12
preparations for medical, dental, or toilet purposes (12) 12
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
acyclic or carbocyclic compounds (3) 3
chemistry (3) 3
diagnosis (3) 3
humans (3) 3
identification (3) 3
male (3) 3
metallurgy (3) 3
organic chemistry (3) 3
surgery (3) 3
adult (2) 2
cross-over studies (2) 2
double-blind method (2) 2
female (2) 2
hypnotics (2) 2
hypnotics and sedatives - adverse effects (2) 2
hypnotics and sedatives - pharmacokinetics (2) 2
middle aged (2) 2
modified release (2) 2
pharmacodynamics (2) 2
pharmacokinetics (2) 2
pharmacology & pharmacy (2) 2
pyridines - adverse effects (2) 2
pyridines - blood (2) 2
pyridines - pharmacokinetics (2) 2
zolpidem (2) 2
abridged index medicus (1) 1
acute coronary syndromes (1) 1
administration, oral (1) 1
adrenoceptor (1) 1
aged (1) 1
aged, 80 and over (1) 1
amiodarone - adverse effects (1) 1
amiodarone - analogs & derivatives (1) 1
amiodarone - therapeutic use (1) 1
amiodarone-like agent (1) 1
analysis of variance (1) 1
anti-arrhythmia agents - adverse effects (1) 1
anti-arrhythmia agents - blood (1) 1
anti-arrhythmia agents - therapeutic use (1) 1
area under curve (1) 1
arrhythmia (1) 1
arrhythmias (1) 1
atrial fibrillation (1) 1
atrial fibrillation - blood (1) 1
atrial fibrillation - drug therapy (1) 1
atrial flutter - drug therapy (1) 1
behavioral pharmacology (1) 1
benzodiazepine agonist (1) 1
beta rhythm - drug effects (1) 1
bioavailability (1) 1
biological availability (1) 1
blood pressure (1) 1
cardiac arrhythmia (1) 1
cardiovascular disease (1) 1
cardiovascular diseases - chemically induced (1) 1
cardiovascular diseases - mortality (1) 1
cerebral infarction (1) 1
chronic disease (1) 1
death (1) 1
delayed-action preparations (1) 1
delayed-action preparations - adverse effects (1) 1
delayed-action preparations - pharmacokinetics (1) 1
digoxin - blood (1) 1
digoxin - therapeutic use (1) 1
double-blind (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
drugs (1) 1
electroencephalography (1) 1
embolism (1) 1
fibrillation (1) 1
flurazepam hydrochloride (1) 1
follow-up (1) 1
follow-up studies (1) 1
half-life (1) 1
headache - chemically induced (1) 1
health aspects (1) 1
healthy-volunteers (1) 1
heart (1) 1
heart diseases (1) 1
heart failure (1) 1
heart failure - chemically induced (1) 1
heart failure - epidemiology (1) 1
heart rate (1) 1
heart rate - drug effects (1) 1
hospitalization (1) 1
hospitalization - statistics & numerical data (1) 1
hypnotics and sedatives - administration & dosage (1) 1
hypnotics and sedatives - blood (1) 1
index medicus (1) 1
infusions, intravenous (1) 1
insomnia (1) 1
intrinsic efficacy (1) 1
medical and health sciences (1) 1
medical research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal Article
01/2013
The present invention relates to the use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of... 
SURGERY | DIAGNOSIS | SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
Patent
01/2011, 7
Método para tratar trastornos del sueno usando eplivanserina. Método para proporcionar eplivanserina. Método para gestionar el riesgo para permitir un uso... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
12/2010
Method for treating sleep disorders by using eplivanserin Method of providing eplivanserin. Method of managing the risk to allow an effective and safe use of... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
06/2010
MÉTODO PARA TRATAR TRASTORNOS DEL SUEÑO USANDO EPLIVANSERINA MÉTODO PARA PROPORCIONAR EPLIVANSERINA. MÉTODO PARA GESTIONAR EL RIESGO PARA PERMITIR UN USO... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
05/2010
Method for treating sleep disorders by using eplivanserin Method of providing eplivanserin. Method of managing the risk to allow an effective and safe use of... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
05/2010
Method for treating sleep disorders by using eplivanserin Method of providing eplivanserin. Method of managing the risk to allow an effective and safe use of... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.